REVEALing the effect of CETP inhibition in cardiovascular disease

被引：40
作者：
Holmes, Michael V. [1 ,2 ,3 ,4 ,5 ]
Smith, George Davey [6 ,7 ,8 ]
机构：
[1] Univ Oxford, Med Res Council, Populat Hlth Res Unit, Oxford OX3 7LF, England
[2] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Roosevelt Dr, Oxford OX3 7LF, England
[3] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit CTSU, Roosevelt Dr, Oxford OX3 7LF, England
[4] Oxford Univ Hosp, Oxford Biomed Res Ctr, Natl Inst Hlth Res, Old Rd, Oxford OX3 7LE, England
[5] Univ Bristol, Med Res Council Integrat Epidemiol Unit, Oakfield House, Bristol BS8 2BN, Avon, England
[6] MRC, Integrat Epidemiol Unit, Oakfield House, Bristol BS8 2BN, Avon, England
[7] Natl Inst Hlth Res, Bristol Biomed Res Ctr, Oakfield House, Bristol BS8 2BN, Avon, England
[8] Univ Bristol, Sch Social & Community Med, Barley House, Bristol BS8 2BN, Avon, England
来源：
NATURE REVIEWS CARDIOLOGY | 2017年 / 14卷 / 11期
基金：
英国医学研究理事会;
关键词：
CORONARY-ARTERY-DISEASE; HIGH-RISK;
D O I：
10.1038/nrcardio.2017.156
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Initial randomized trials of cholesteryl ester transfer protein (CETP) inhibitors were terminated early owing to adverse effects or futility. The REVEAL trial now shows the benefit of CETP inhibition in coronary heart disease. Despite raising HDL-cholesterol levels, the cardiovascular effect of CETP inhibitors is probably due to lowering of non-HDL-cholesterol levels.
引用
收藏
页码：635 / 636
页数：2
相关论文
共 50 条
[41]   HDL in Atherosclerotic Cardiovascular Disease: In Search of a Role [J].
Casula, Manuela ;
Colpani, Ornella ;
Xie, Sining ;
Catapano, Alberico L. ;
Baragetti, Andrea .
CELLS, 2021, 10 (08)
[42]   Shared Mechanisms between Cardiovascular Disease and NAFLD [J].
Huang, Daniel Q. ;
Downes, Michael ;
Evans, Ronald M. ;
Witztum, Joseph L. ;
Glass, Christopher K. ;
Loomba, Rohit .
SEMINARS IN LIVER DISEASE, 2022, 42 (04) :455-464
[43]   Selective and specific I-f inhibition with ivabradine: new perspectives for the treatment of cardiovascular disease [J].
Ferrari, Roberto ;
Ceconi, Claudio .
EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2011, 9 (08) :959-973
[44]   Genetic Effect on Body Mass Index and Cardiovascular Disease Across Generations [J].
Sarnowski, Chloe ;
Conomos, Matthew P. ;
Vasan, Ramachandran S. ;
Meigs, James B. ;
Dupuis, Josee ;
Liu, Ching-Ti ;
Leong, Aaron .
CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2023, 16 (01) :80-86
[45]   The pig as a valuable model for testing the effect of resveratrol to prevent cardiovascular disease [J].
Elmadhun, Nassrene Y. ;
Sabe, Ashraf A. ;
Robich, Michael P. ;
Chu, Louis M. ;
Lassaletta, Antonio D. ;
Sellke, Frank W. .
RESVERATROL AND HEALTH, 2013, 1290 :130-135
[46]   Effect of Obesity on Cardiovascular Disease Risk Factors in African American Women [J].
Henry-Okafor, Queen ;
Cowan, Patricia A. ;
Wicks, Mona N. ;
Rice, Muriel ;
Husch, Donna S. ;
Khoo, Michelle S. C. .
BIOLOGICAL RESEARCH FOR NURSING, 2012, 14 (02) :171-179
[47]   Anacetrapib reduces (V)LDL cholesterol by inhibition of CETP activity and reduction of plasma PCSK9 [J].
van der Tuin, Sam J. L. ;
Kuhnast, Susan ;
Berbee, Jimmy F. P. ;
Verschuren, Lars ;
Pieterman, Elsbet J. ;
Havekes, Louis M. ;
van der Hoorn, Jose W. A. ;
Rensen, Patrick C. N. ;
Jukema, J. Wouter ;
Princen, Hans M. G. ;
van Dijk, Ko Willems ;
Wang, Yanan .
JOURNAL OF LIPID RESEARCH, 2015, 56 (11) :2085-2093
[48]   CETP (Cholesteryl Ester Transfer Protein) Concentration A Genome-Wide Association Study Followed by Mendelian Randomization on Coronary Artery Disease [J].
Blauw, Lisanne L. ;
Li-Gao, Ruifang ;
Noordam, Raymond ;
de Mutsert, Renee ;
Trompet, Stella ;
Berbee, Jimmy F. P. ;
Wang, Yanan ;
van Klinken, Jan B. ;
Christen, Tim ;
van Heemst, Diana ;
Mook-Kanamori, Dennis O. ;
Rosendaal, Frits R. ;
Jukema, J. Wouter ;
Rensen, Patrick C. N. ;
van Dijk, Ko Willems .
CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2018, 11 (05) :e002034
[49]   Circulating Biomarkers for Cardiovascular Disease Risk Prediction in Patients With Cardiovascular Disease [J].
Wong, Yuen-Kwun ;
Tse, Hung-Fat .
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
[50]   Cholesteryl ester transfer protein inhibition in the management of atherosclerotic cardiovascular disease: second act "A rebirth of hope" [J].
Arteaga, Antonio ;
Rigotti, Attilio .
REVISTA MEDICA DE CHILE, 2011, 139 (06) :802-806
12345